Non-invasive Diagnosis of Parkinson's Disease

Non-invasive Diagnosis of Parkinson's Disease Using Hyperspectral Retinal Imaging, Optical Coherence Tomography, Computerized Cognitive Testing, and Voice Analysis

NCT07201610•Blekinge Institute of Technology

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Parkinsons Disease (PD)

Key Dates

Start Date

October 16, 2025

Primary Completion Date

December 16, 2025

Completion Date

December 16, 2025

Last Updated

October 1, 2025

Contacts

Anders Behrens, MD. PhD.

CONTACT

0046455731000 anders.behrens@bth.se

Sponsors

Lead Sponsor

Blekinge Institute of Technology

Collaborators

Region Blekinge

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 1, 2025Data synced to Clareo: April 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions